Merit Financial Group
ABBV icon

Merit Financial Group’s AbbVie ABBV Stock Holding History

Merit Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.7M Buy
113,607
+4,955
+5% +$1.27M 0.17% 109
2026
Q2 		$27.3M Buy
108,652
+3,742
+4% +$805K 0.17% 107
2026
Q1 		$22.8M Buy
104,910
+11,615
+12% +$2.58M 0.17% 106
2025
Q4 		$21.3M Buy
93,295
+11,253
+14% +$2.56M 0.17% 103
2025
Q3 		$19M Buy
82,042
+2,461
+3% +$501K 0.17% 103
2025
Q2 		$14.8M Buy
79,581
+20,548
+35% +$3.82M 0.16% 100
2025
Q1 		$12.4M Buy
59,033
+9,807
+20% +$1.91M 0.19% 92
2024
Q4 		$8.75M Buy
49,226
+1,375
+3% +$253K 0.16% 119
2024
Q3 		$9.45M Buy
47,851
+1,163
+2% +$217K 0.21% 82
2024
Q2 		$8.01M Buy
46,688
+2,399
+5% +$397K 0.18% 96
2024
Q1 		$7.25M Buy
44,289
+18,522
+72% +$3.19M 0.17% 101
2023
Q4 		$3.99M Sell
25,767
-14,814
-37% -$2.16M 0.12% 119
2023
Q3 		$6.05M Buy
40,581
+2,151
+6% +$316K 0.2% 80
2023
Q2 		$5.18M Buy
38,430
+7,149
+23% +$1.05M 0.17% 93
2023
Q1 		$4.99M Sell
31,281
-1,804
-5% -$276K 0.18% 87
2022
Q4 		$5.35M Buy
33,085
+1,634
+5% +$251K 0.19% 78
2022
Q3 		$4.22M Sell
31,451
-8,039
-20% -$1.15M 0.18% 75
2022
Q2 		$6.05M Buy
39,490
+25,753
+187% +$3.94M 0.19% 77
2022
Q1 		$2.23M Buy
13,737
+842
+7% +$122K 0.13% 97
2021
Q4 		$1.75M Sell
12,895
-217
-2% -$25.6K 0.17% 65
2021
Q3 		$1.41M Buy
13,112
+108
+0.8% +$12.3K 0.15% 74
2021
Q2 		$1.46M Buy
13,004
+40
+0.3% +$4.5K 0.14% 75
2021
Q1 		$1.4M Buy
12,964
+956
+8% +$102K 0.15% 71
2020
Q4 		$1.29M Buy
12,008
+2,001
+20% +$192K 0.12% 68
2020
Q3 		$876K Buy
10,007
+1,773
+22% +$167K 0.08% 96
2020
Q2 		$808K Buy
8,234
+1,247
+18% +$110K 0.08% 93
2020
Q1 		$532K Buy
6,987
+256
+4% +$21.8K 0.06% 118
2019
Q4 		$596K Buy
+6,731
New +$559K 0.05% 122

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Merit Financial Group's ABBV Position: Q3 2026 in Review

Merit Financial Group increased its AbbVie (ABBV) stake by 4.6% in Q3 2026, buying an estimated $1.27M and bringing the position to 113,607 shares worth $29.7M. The position accounts for 0.17% of the portfolio, ranked #109.

Merit Financial Group first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 2,727 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Merit Financial Group held 113,607 shares of AbbVie worth $29.7M as of Q3 2026.
  • Merit Financial Group bought 4,955 AbbVie shares in Q3 2026, an estimated $1.27M.
  • AbbVie made up 0.17% of Merit Financial Group's portfolio in Q3 2026, its #109 holding.
  • Merit Financial Group first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 2,727 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.